Shigeo Ichihashi/LinkedIn
Oct 18, 2025, 05:13
The CLARIFY IMA Study From Shigeo Ichihashi and Colleagues was Recently Published!
Vascular News shared Shigeo Ichihashi’s and colleagues latest study on LinkedIn:
“Results from a multicentre randomised controlled trial indicate that pre-emptive inferior mesenteric artery (IMA) embolisation during endovascular aneurysm repair (EVAR) does not significantly reduce aneurysm sac volume or rates of type II endoleak.
The CLARIFY IMA study from Shigeo Ichihashi (Nara Medical University, Nara, Japan) and colleagues was recently published in the European Journal of Vascular and Endovascular Surgery (EJVES) and presented at the 39th European Society for Vascular Surgery annual meeting (23–26 September, Istanbul, Türkiye).”

Read more here.
Stay updated about IMA latest news with Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD
